Optimal glycemic control with insulin detemir and aspart improves lipoprotein composition and particle number/size in poorly controlled T2DM

被引：0
|
作者：
Kumar, Pratima
Wang, Shaoyun
Balas, Bogdana
Darland, Celia
Walz, Barbara
Johnson, Lisa
Mathew, Manoj
Cusi, Kenneth
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A254 / A255
页数：2
相关论文
共 50 条
  • [21] Human Hyaluronidase plus Rapid Analog Insulin (RAI) Improves Postprandial Glycemic Control in Type 2 Diabetes (T2DM) Compared to Insulin Lispro Alone
    Bergenstal, Richard M.
    Klonoff, David
    Bailey, Timothy
    Vaughn, Daniel E.
    Muchmore, Douglas B.
    DIABETES, 2012, 61 : A224 - A224
  • [22] Biphasic insulin aspart 30 combined with metformin provides better glycemic control in poorly controlled type 2 diabetic patients
    Kvapil, M
    Mikolajczyk-Swatko, A
    Ostergaard, AH
    Shestakova, M
    DIABETES, 2002, 51 : A104 - A105
  • [23] Dapagliflozin Improves Glycemic Control and Reduces Body Weight in Patients With T2DM across the Treatment Continuum
    Salsali, Afshin
    Wei, Li
    Wessman, Catrin
    Hardy, Elise
    Ptaszynska, Agata
    Parikh, Shamik
    DIABETES, 2012, 61 : A593 - A594
  • [24] Empagliflozin Monotherapy for 12 Weeks Improves Glycemic Control in Japanese Patients With Type 2 Diabetes (T2DM)
    Kadowaki, Takashi
    Haneda, Masakazu
    Inagaki, Nobuya
    Taniguchi, Atsushi
    Sakamoto, Masashi
    Koiwai, Kazuki
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2013, 62 : A297 - A298
  • [25] Gastric banding improves short- and long-term glycemic control in T2DM patients
    Fried, M.
    Owen, K.
    Dolezalova, K.
    OBESITY SURGERY, 2008, 18 (04) : 456 - 456
  • [26] Advancing insulin therapy in T2DM: Emerging dynamics among parameters affecting tight glycemic control
    Johnson, Mary
    Powers, Margaret A.
    Hollander, Priscilla
    Vlajnic, Aleksandra
    Bergenstal, Richard
    DIABETES, 2007, 56 : A556 - A556
  • [27] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Ting-Ting Yin
    Yan Bi
    Ping Li
    Shan-Mei Shen
    Xiao-Lu Xiong
    Li-Jun Gao
    Can Jiang
    Yan Wang
    Wen-Huan Feng
    Da-Long Zhu
    Diabetes Therapy, 2018, 9 : 1253 - 1267
  • [28] Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial
    Yin, Ting-Ting
    Bi, Yan
    Li, Ping
    Shen, Shan-Mei
    Xiong, Xiao-Lu
    Gao, Li-Jun
    Jiang, Can
    Wang, Yan
    Feng, Wen-Huan
    Zhu, Da-Long
    DIABETES THERAPY, 2018, 9 (03) : 1253 - 1267
  • [29] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Haering, Hans-Ulrich
    Merker, Ludwig
    Seewaldt-Becker, Elke
    Weimer, Marc
    Meinicke, Thomas
    Broedl, Uli C.
    Woerle, Hans J.
    DIABETES, 2013, 62 : A282 - A282
  • [30] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)
    Kovacs, Christopher
    Seshiah, Veeraswamy
    Swallow, Ros
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    DIABETES, 2013, 62 : A291 - A291
12345